Nerandomilast + Mao Inhibitors Interaction
Moderateinteraction on record
Description
Strong CYP3A inhibitors increase exposure of nerandomilast, which may increase the risk of JASCAYD adverse reactions. Dosage reduction to 9 mg twice daily is recommended.
Mechanism
Inhibition of CYP3A metabolism increases nerandomilast exposure
Source: NLP:nerandomilast